MannKind Corp Reports Q3 2026 Results: Revenue of $101.9M Misses Estimates, GAAP EPS of -$0. ...
Commercial product sales more than double as Furoscix ReadyFlow adoption accelerates, while a GAAP net loss of $23.2 million widens year over year Related Stocks: MNKD ,